Skip to main content
. 2016 May 23;7(25):38598–38611. doi: 10.18632/oncotarget.9560

Figure 5. Roscovitine induces DNA damage exclusively in HPV+ head and neck cancer cells.

Figure 5

A. Representative images of Comet assay from HPV- SCC61 and HPV+ UMSCC47 cells untreated or treated with roscovitine for 24 hours. B. Quantification of Comet assay from two independent experiments.